A demonstration based on multi-omics transcriptome sequencing data revealed disulfidptosis heterogeneity within the tumor microenvironment of esophageal squamous cell carcinoma

Abstract Background It is of great concern to identify prognostic signatures for the prediction and prediction of esophageal squamous cell carcinoma (ESCC), which is the lethal pathological type of malignancy. Method Bulk RNA sequencing and scRNA-seq data were retrieved from GSE53624, GSE53622, and...

Full description

Bibliographic Details
Main Authors: Fuxing Liu, Donglan Yuan, Xia Liu, Shichao Zhuo, Xinyun Liu, Haihui Sheng, Min Sha, Jun Ye, Hong Yu
Format: Article
Language:English
Published: Springer 2023-06-01
Series:Discover Oncology
Subjects:
Online Access:https://doi.org/10.1007/s12672-023-00711-5
_version_ 1797801403733770240
author Fuxing Liu
Donglan Yuan
Xia Liu
Shichao Zhuo
Xinyun Liu
Haihui Sheng
Min Sha
Jun Ye
Hong Yu
author_facet Fuxing Liu
Donglan Yuan
Xia Liu
Shichao Zhuo
Xinyun Liu
Haihui Sheng
Min Sha
Jun Ye
Hong Yu
author_sort Fuxing Liu
collection DOAJ
description Abstract Background It is of great concern to identify prognostic signatures for the prediction and prediction of esophageal squamous cell carcinoma (ESCC), which is the lethal pathological type of malignancy. Method Bulk RNA sequencing and scRNA-seq data were retrieved from GSE53624, GSE53622, and GSE188900. Disulfidptosis-related differentially expressed genes (DEGs) were identified between disulfidptosis-high score and disulfidptosis-low score groups. Functional annotation of DEGs were analyzed by Gene Ontology (GO). Consistent clustering and co-expression modules were analyzed, and then constructed a risk score model via multivariate Cox regression analysis. Immune infiltration and immunotherapy response analyses were conducted based on risk score. qRT-PCR, colony formation assay, and flow cytometry analysis were conducted in KYSE-150 and TE-1 cell lines. Results Seven genes (CD96, CXCL13, IL2RG, LY96, TPK1, ACAP1, and SOX17) were selected as marker genes. CD96 and SOX17 are independent prognostic signatures for ESCC patients, with a significant correlation with infiltrated immune cells. ESCC patients had worse response to nivolumab in the high-risk group. Through cellular experiments, we found that CD96 expression was associated with apoptosis and cell cycle ESCC cells. Conclusion In a word, the risk score based on disulfidptosis is associated with prognosis and the immune microenvironment, which may direct immunotherapy of ESCC. The key gene of risk score, namely CD96, plays a role in proliferation and apoptosis in ESCC. We offer an insight into the exploration of the genomic etiology of ESCC for its clinical management.
first_indexed 2024-03-13T04:49:57Z
format Article
id doaj.art-e161928976fc4c0ab0b50266e3dc886d
institution Directory Open Access Journal
issn 2730-6011
language English
last_indexed 2024-03-13T04:49:57Z
publishDate 2023-06-01
publisher Springer
record_format Article
series Discover Oncology
spelling doaj.art-e161928976fc4c0ab0b50266e3dc886d2023-06-18T11:17:40ZengSpringerDiscover Oncology2730-60112023-06-0114111810.1007/s12672-023-00711-5A demonstration based on multi-omics transcriptome sequencing data revealed disulfidptosis heterogeneity within the tumor microenvironment of esophageal squamous cell carcinomaFuxing Liu0Donglan Yuan1Xia Liu2Shichao Zhuo3Xinyun Liu4Haihui Sheng5Min Sha6Jun Ye7Hong Yu8Department of Pathology, The Affiliated Taizhou People’s Hospital of Nanjing Medical UniversityDepartment of Gynecology, The Affiliated Taizhou People’s Hospital of Nanjing Medical UniversityDepartment of Pathology, Xuzhou Central Hospital Affiliated to Nanjing University of Chinese MedicineDepartment of Pathology, Xuzhou Central Hospital Affiliated to Nanjing University of Chinese MedicineDepartment of Pathology, The Affiliated Taizhou People’s Hospital of Nanjing Medical UniversityDepartment of Pathology, The Affiliated Taizhou People’s Hospital of Nanjing Medical UniversityTranslational Medicine Center, The Affiliated Taizhou People’s Hospital of Nanjing Medical UniversityTranslational Medicine Center, The Affiliated Taizhou People’s Hospital of Nanjing Medical UniversityDepartment of Pathology, The Affiliated Taizhou People’s Hospital of Nanjing Medical UniversityAbstract Background It is of great concern to identify prognostic signatures for the prediction and prediction of esophageal squamous cell carcinoma (ESCC), which is the lethal pathological type of malignancy. Method Bulk RNA sequencing and scRNA-seq data were retrieved from GSE53624, GSE53622, and GSE188900. Disulfidptosis-related differentially expressed genes (DEGs) were identified between disulfidptosis-high score and disulfidptosis-low score groups. Functional annotation of DEGs were analyzed by Gene Ontology (GO). Consistent clustering and co-expression modules were analyzed, and then constructed a risk score model via multivariate Cox regression analysis. Immune infiltration and immunotherapy response analyses were conducted based on risk score. qRT-PCR, colony formation assay, and flow cytometry analysis were conducted in KYSE-150 and TE-1 cell lines. Results Seven genes (CD96, CXCL13, IL2RG, LY96, TPK1, ACAP1, and SOX17) were selected as marker genes. CD96 and SOX17 are independent prognostic signatures for ESCC patients, with a significant correlation with infiltrated immune cells. ESCC patients had worse response to nivolumab in the high-risk group. Through cellular experiments, we found that CD96 expression was associated with apoptosis and cell cycle ESCC cells. Conclusion In a word, the risk score based on disulfidptosis is associated with prognosis and the immune microenvironment, which may direct immunotherapy of ESCC. The key gene of risk score, namely CD96, plays a role in proliferation and apoptosis in ESCC. We offer an insight into the exploration of the genomic etiology of ESCC for its clinical management.https://doi.org/10.1007/s12672-023-00711-5DisulfidptosisEsophageal squamous cell carcinomaRisk scoreTumor microenvironmentCD96
spellingShingle Fuxing Liu
Donglan Yuan
Xia Liu
Shichao Zhuo
Xinyun Liu
Haihui Sheng
Min Sha
Jun Ye
Hong Yu
A demonstration based on multi-omics transcriptome sequencing data revealed disulfidptosis heterogeneity within the tumor microenvironment of esophageal squamous cell carcinoma
Discover Oncology
Disulfidptosis
Esophageal squamous cell carcinoma
Risk score
Tumor microenvironment
CD96
title A demonstration based on multi-omics transcriptome sequencing data revealed disulfidptosis heterogeneity within the tumor microenvironment of esophageal squamous cell carcinoma
title_full A demonstration based on multi-omics transcriptome sequencing data revealed disulfidptosis heterogeneity within the tumor microenvironment of esophageal squamous cell carcinoma
title_fullStr A demonstration based on multi-omics transcriptome sequencing data revealed disulfidptosis heterogeneity within the tumor microenvironment of esophageal squamous cell carcinoma
title_full_unstemmed A demonstration based on multi-omics transcriptome sequencing data revealed disulfidptosis heterogeneity within the tumor microenvironment of esophageal squamous cell carcinoma
title_short A demonstration based on multi-omics transcriptome sequencing data revealed disulfidptosis heterogeneity within the tumor microenvironment of esophageal squamous cell carcinoma
title_sort demonstration based on multi omics transcriptome sequencing data revealed disulfidptosis heterogeneity within the tumor microenvironment of esophageal squamous cell carcinoma
topic Disulfidptosis
Esophageal squamous cell carcinoma
Risk score
Tumor microenvironment
CD96
url https://doi.org/10.1007/s12672-023-00711-5
work_keys_str_mv AT fuxingliu ademonstrationbasedonmultiomicstranscriptomesequencingdatarevealeddisulfidptosisheterogeneitywithinthetumormicroenvironmentofesophagealsquamouscellcarcinoma
AT donglanyuan ademonstrationbasedonmultiomicstranscriptomesequencingdatarevealeddisulfidptosisheterogeneitywithinthetumormicroenvironmentofesophagealsquamouscellcarcinoma
AT xialiu ademonstrationbasedonmultiomicstranscriptomesequencingdatarevealeddisulfidptosisheterogeneitywithinthetumormicroenvironmentofesophagealsquamouscellcarcinoma
AT shichaozhuo ademonstrationbasedonmultiomicstranscriptomesequencingdatarevealeddisulfidptosisheterogeneitywithinthetumormicroenvironmentofesophagealsquamouscellcarcinoma
AT xinyunliu ademonstrationbasedonmultiomicstranscriptomesequencingdatarevealeddisulfidptosisheterogeneitywithinthetumormicroenvironmentofesophagealsquamouscellcarcinoma
AT haihuisheng ademonstrationbasedonmultiomicstranscriptomesequencingdatarevealeddisulfidptosisheterogeneitywithinthetumormicroenvironmentofesophagealsquamouscellcarcinoma
AT minsha ademonstrationbasedonmultiomicstranscriptomesequencingdatarevealeddisulfidptosisheterogeneitywithinthetumormicroenvironmentofesophagealsquamouscellcarcinoma
AT junye ademonstrationbasedonmultiomicstranscriptomesequencingdatarevealeddisulfidptosisheterogeneitywithinthetumormicroenvironmentofesophagealsquamouscellcarcinoma
AT hongyu ademonstrationbasedonmultiomicstranscriptomesequencingdatarevealeddisulfidptosisheterogeneitywithinthetumormicroenvironmentofesophagealsquamouscellcarcinoma
AT fuxingliu demonstrationbasedonmultiomicstranscriptomesequencingdatarevealeddisulfidptosisheterogeneitywithinthetumormicroenvironmentofesophagealsquamouscellcarcinoma
AT donglanyuan demonstrationbasedonmultiomicstranscriptomesequencingdatarevealeddisulfidptosisheterogeneitywithinthetumormicroenvironmentofesophagealsquamouscellcarcinoma
AT xialiu demonstrationbasedonmultiomicstranscriptomesequencingdatarevealeddisulfidptosisheterogeneitywithinthetumormicroenvironmentofesophagealsquamouscellcarcinoma
AT shichaozhuo demonstrationbasedonmultiomicstranscriptomesequencingdatarevealeddisulfidptosisheterogeneitywithinthetumormicroenvironmentofesophagealsquamouscellcarcinoma
AT xinyunliu demonstrationbasedonmultiomicstranscriptomesequencingdatarevealeddisulfidptosisheterogeneitywithinthetumormicroenvironmentofesophagealsquamouscellcarcinoma
AT haihuisheng demonstrationbasedonmultiomicstranscriptomesequencingdatarevealeddisulfidptosisheterogeneitywithinthetumormicroenvironmentofesophagealsquamouscellcarcinoma
AT minsha demonstrationbasedonmultiomicstranscriptomesequencingdatarevealeddisulfidptosisheterogeneitywithinthetumormicroenvironmentofesophagealsquamouscellcarcinoma
AT junye demonstrationbasedonmultiomicstranscriptomesequencingdatarevealeddisulfidptosisheterogeneitywithinthetumormicroenvironmentofesophagealsquamouscellcarcinoma
AT hongyu demonstrationbasedonmultiomicstranscriptomesequencingdatarevealeddisulfidptosisheterogeneitywithinthetumormicroenvironmentofesophagealsquamouscellcarcinoma